OM:ESSITY B
OM:ESSITY BHousehold Products

Are Essity Shares Attractively Priced After Recent Surge and Sustainability Initiatives?

Thinking about whether Essity is a bargain or overpriced? Let's investigate what its current share price means for potential investors like you. Essity's stock has seen a slight dip of 0.3% over the past week, yet it surged 5.4% in the last month, even as the longer-term performance remains mixed. Recent headlines spotlight Essity's strategic moves in sustainability and product innovation, fueling conversations about its growth prospects and how these efforts might offset broader market...
OM:CAMX
OM:CAMXPharmaceuticals

A Look at Camurus (OM:CAMX) Valuation Following European Launch of Oczyesa for Acromegaly

Camurus (OM:CAMX) has launched Oczyesa, a long-acting octreotide medication for adults with acromegaly. The drug is now first available in Germany after receiving marketing authorization from the European Commission. The drug can be self-administered using an autoinjector pen, a feature designed to improve both convenience and overall quality of life for patients managing this rare condition. See our latest analysis for Camurus. On the back of the Oczyesa launch, Camurus has seen its momentum...
OM:ACARIX
OM:ACARIXMedical Equipment

European Penny Stocks To Consider In November 2025

As the European market navigates a mixed landscape with major stock indexes showing varied performance, investors are keeping a close eye on opportunities that may arise from current economic conditions. Penny stocks, often associated with smaller or newer companies, continue to offer intriguing prospects despite their somewhat outdated moniker. These stocks can provide an affordable entry point into the market and potential growth when backed by strong financials. In this article, we explore...
OM:IMP A SDB
OM:IMP A SDBMedical Equipment

Assessing Implantica (OM:IMP A SDB) Valuation Following FDA Progress for RefluxStop Device

Implantica (OM:IMP A SDB) saw momentum build this week after the company received positive feedback from the FDA on its RefluxStop device. Recent inspections wrapped up smoothly and set the stage for potential U.S. market entry. See our latest analysis for Implantica. That FDA feedback has energized investors, but it comes after an intense year of ups and downs for Implantica. Despite a sharp short-term pullback, such as a 25.9% one-month share price return, the stock's 43.7% year-to-date...
OM:GETI B
OM:GETI BMedical Equipment

Getinge (OM:GETI B): Assessing Valuation as Guidance Holds Firm Despite Tariffs and Currency Pressures

Getinge (OM:GETI B) reaffirmed its guidance for 2025, confirming expectations for 2% to 5% organic net sales growth and targeting over 12% earnings per share growth, even with ongoing headwinds from tariffs and currency shifts. See our latest analysis for Getinge. Backed by steady guidance and resilience in the face of tariffs and currency changes, Getinge’s shares have climbed with conviction this year, posting a robust 21.6% year-to-date share price return and an impressive 1-year total...
OM:NOLA B
OM:NOLA BIndustrials

Nolato (OM:NOLA B): Evaluating Valuation Potential After Earnings Growth Outpaces Sales Decline

Nolato (OM:NOLA B) just released its third quarter and nine-month earnings, showing an uptick in both net income and earnings per share compared to last year, even as sales edged down slightly. Investors are paying close attention. See our latest analysis for Nolato. Nolato’s steady earnings progress has caught the market’s attention, especially as the 1-year total shareholder return sits at 14% and the share price is up nearly 14% year-to-date. While momentum has picked up in recent months,...
OM:SKF B
OM:SKF BMachinery

AB SKF (OM:SKF B) Valuation in Focus After Lower Q3 Results and Cautious Outlook

AB SKF (OM:SKF B) published its third-quarter results, revealing a decline in both sales and net income compared to last year. The company also shared a cautious outlook, highlighting ongoing economic uncertainty and an expected negative impact from currency movements. See our latest analysis for AB SKF. Despite the recent dip in quarterly sales and the announcement of some operational changes, AB SKF’s total shareholder return has climbed an impressive 24% over the past year, outpacing its...
OM:CS
OM:CSCapital Markets

CoinShares’ Launch of Staked Toncoin ETP Could Be a Game Changer for CoinShares International (OM:CS)

CoinShares International recently launched the CoinShares Physical Staked Toncoin, a regulated exchange-traded product providing direct exposure to Toncoin, a blockchain integrated with Telegram's global platform, following its announced merger with Vine Hill Capital Investment Corp. This product stands out by offering 0% management fees and staking yield, leveraging Telegram’s 900 million–plus user base for real-world blockchain utility. We’ll examine how CoinShares’ integration of...
OM:TELIA
OM:TELIATelecom

Telia Company (OM:TELIA) Valuation in Focus After Mixed Earnings and Recent Share Price Gain

Telia Company (OM:TELIA) released its third quarter earnings, highlighting stable sales and a slight increase in quarterly net income. However, nine-month results reflected lower net income and earnings per share compared to last year. See our latest analysis for Telia Company. Despite Telia's mixed earnings, the stock has maintained upward momentum, with a 5.2% one-month share price return and a strong 19.5% year-to-date increase. Looking to the long term, total shareholder return stands at...
OM:MTG B
OM:MTG BEntertainment

Does MTG’s Share Buyback Reflect a Shift in Capital Allocation Priorities for OM:MTG B?

Modern Times Group MTG announced in October 2025 that it had started a share repurchase program, following authorization from its May 2025 Annual General Meeting, with plans to buy back up to 12,203,000 shares, representing 10% of its issued share capital, or spend up to SEK400 million by May 2026. This buyback program allows MTG not only to enhance long-term shareholder value and returns but also to provide shares for its long-term incentive initiatives. With the share buyback program...
OM:BILI A
OM:BILI ASpecialty Retail

Is Bilia's Strong Q3 Earnings Momentum Altering the Investment Case for Bilia (OM:BILI A)?

Bilia AB reported its third quarter 2025 earnings, showing sales of SEK 9,717 million and net income of SEK 191 million, both higher compared to the previous year. A significant year-over-year increase in both quarterly and nine-month earnings highlights stronger operational performance across the company’s core segments. We'll explore how Bilia's improved earnings and sales growth might influence its investment narrative and future prospects. The end of cancer? These 29 emerging AI stocks...
OM:EPRO B
OM:EPRO BMachinery

Electrolux Professional (OM:EPRO B) Is Down 6.1% After Cost-Cutting Plan and Weaker Q3 Results – What’s Changed

Electrolux Professional AB recently reported third-quarter 2025 results, with sales of SEK 2,816 million and net income of SEK 40 million, both down compared to the same period last year. Alongside the subdued earnings, the company introduced a major efficiency program targeting SEK 85 million in cost savings and a workforce reduction affecting 350 employees, aiming to counter market pressures and improve profitability. We'll examine how Electrolux Professional's new cost-saving initiative...
OM:ITAB
OM:ITABCommercial Services

European Growth Stocks With High Insider Ownership November 2025

As the European markets navigate a landscape of mixed stock index performances and steady interest rates from the European Central Bank, investors are keenly observing sectors that can thrive amid these conditions. In such an environment, growth companies with high insider ownership often stand out as they may signal strong internal confidence and commitment to long-term success.